Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
ZT-12-037-01
Cat. No.:
OB0225LY-0040
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR and LC-MS.
Size:
Add to basket
Product Overview
Description:
ZT-12-037-01 is a small molecule inhibitor that targets specific protein interactions and pathways involved in cell proliferation and survival.
Synonym:
2328073-61-4; N2-Cyclopropyl-N4-(1-isopropylpiperidin-4-yl)-6,7-dimethoxyquinazoline-2,4-diamine; 2-N-Cyclopropyl-6,7-dimethoxy-4-N-(1-propan-2-ylpiperidin-4-yl)quinazoline-2,4-diamine
CAS No.:
2328073-61-4
Compound CID:
138911316
Formula:
C21H31N5O2
Formula Weight:
385.5
Specification
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
ZT-12-037-01 can be used as a ATP competitive STK19 inhibitor.
Library Information
Targets:
Serine protease; Ras
Receptors:
STK19
Pathways:
MAPK; Proteases/Proteasome; GPCR/G protein
Plate Number:
AOCL-1
Plate Location:
e2
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
41 mg/mL; 106.36 mM
